{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:08:03Z","timestamp":1789204083716,"version":"build-2803163510"},"publisher-location":"Berlin, Heidelberg","reference-count":93,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/164_2026_852","type":"book-chapter","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:39:18Z","timestamp":1789202358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biological and Medicinal Aspects of Peptides and Sugar-Based Boron-Containing Compounds"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5520-3128","authenticated-orcid":false,"given":"Emily L.","family":"Krinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5943-0684","authenticated-orcid":false,"given":"Reilly K.","family":"Gwinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-8548","authenticated-orcid":false,"given":"Webster L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,13]]},"reference":[{"issue":"1","key":"852_CR1","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1021\/ACSOMEGA.4C09745","volume":"10","author":"B Akyol","year":"2024","unstructured":"Akyol B, \u00c7okluk EM, Ayhan MM, Tuncel Kostako\u011flu S, G\u00fcrek AG (2024) Tuning the photophysical properties of BODIPY dyes and studying their self-assembly via hydrogen bonding. ACS Omega 10(1):1716\u20131726. https:\/\/doi.org\/10.1021\/ACSOMEGA.4C09745","journal-title":"ACS Omega"},{"issue":"3","key":"852_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM14030264","volume":"14","author":"O Al Musaimi","year":"2024","unstructured":"Al Musaimi O (2024) Exploring FDA-approved Frontiers: insights into natural and engineered peptide analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and \u03b1-MSH realms. Biomol 14(3):264. https:\/\/doi.org\/10.3390\/BIOM14030264","journal-title":"Biomol"},{"key":"852_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainres.2011.06.042","volume":"1407","author":"AG Almonte","year":"2011","unstructured":"Almonte AG, Sweatt JD (2011) Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res 1407:107\u2013122. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.042","journal-title":"Brain Res"},{"key":"852_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.17179\/excli2022-5653","volume":"22","author":"M Alwahsh","year":"2023","unstructured":"Alwahsh M, Farhat J, Talhouni S, Hamadneh L, Hergenr\u00f6der R (2023) Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications. EXCLI J 22:146\u2013168. https:\/\/doi.org\/10.17179\/excli2022-5653","journal-title":"EXCLI J"},{"issue":"4","key":"852_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/plants12040777","volume":"12","author":"L Bola\u00f1os","year":"2023","unstructured":"Bola\u00f1os L, Abreu I, Bonilla I, Camacho-Crist\u00f3bal JJ, Reguera M (2023) What can boron deficiency symptoms tell us about its function and regulation? Plants 12(4):777. https:\/\/doi.org\/10.3390\/plants12040777","journal-title":"Plants"},{"issue":"18","key":"852_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115658","volume":"22","author":"B Borek","year":"2020","unstructured":"Borek B, Gajda T, Golebiowski A, Blaszczyk R (2020) Boronic acid-based arginase inhibitors in cancer immunotherapy. Bioorg Med Chem 22(18):115658. https:\/\/doi.org\/10.1016\/j.bmc.2020.115658","journal-title":"Bioorg Med Chem"},{"key":"852_CR7","unstructured":"Boron https:\/\/ods.od.nih.gov\/factsheets\/Boron-HealthProfessional%20\/#en1. Accessed 9 Dec 2025"},{"issue":"9","key":"852_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1039\/b904304g","volume":"5","author":"DI Bryson","year":"2009","unstructured":"Bryson DI, Zhang W, Ray WK, Santos WL (2009) Screening of a branched peptide library with HIV-1 TAR RNA. Mol BioSyst 5(9):1070\u20131073. https:\/\/doi.org\/10.1039\/b904304g","journal-title":"Mol BioSyst"},{"issue":"6","key":"852_CR9","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/SMLL.201201928","volume":"9","author":"CS Chen","year":"2013","unstructured":"Chen CS, Xu XD, Wang Y, Yang J, Jia HZ, Cheng H, Chu CC, Zhuo RX, Zhang XZ (2013) A peptide nanofibrous indicator for eye-detectable cancer cell identification. Small 9(6):920\u2013926. https:\/\/doi.org\/10.1002\/SMLL.201201928","journal-title":"Small"},{"key":"852_CR10","doi-asserted-by":"publisher","unstructured":"Chormova D, Messenger DJ, Fry SC (2014) Rhamnogalacturonan-II cross-linking of plant pectins via boron bridges occurs during polysaccharide synthesis and\/or secretion. Plant Signal Behav 9(3). https:\/\/doi.org\/10.4161\/PSB.28169","DOI":"10.4161\/PSB.28169"},{"issue":"3","key":"852_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0360-3016(92)90951-D","volume":"30","author":"JA Coderre","year":"1994","unstructured":"Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB (1994) Neutron capture therapy of the 9l rat Gliosarcoma using the P-Boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30(3):643\u2013652. https:\/\/doi.org\/10.1016\/0360-3016(92)90951-D","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"852_CR12","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1021\/jm800390n","volume":"51","author":"BA Connolly","year":"2008","unstructured":"Connolly BA, Sanford DG, Chiluwal AK, Healey SE, Peters DE, Dimare MT, Wu W, Liu Y, Maw H, Zhou Y, Li Y, Jin Z, Sudmeier JL, Lai JH, Bachovchin WW (2008) Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety. J Med Chem 51(19):6005\u20136013. https:\/\/doi.org\/10.1021\/jm800390n","journal-title":"J Med Chem"},{"issue":"9","key":"852_CR13","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1021\/ac2002565","volume":"83","author":"BJ Crumpton","year":"2011","unstructured":"Crumpton BJ, Zhang W, Santos LW (2011) Facile analysis and sequencing of linear and branched peptide boronic acids by MALDI mass spectrometry. Anal Chem 83(9):3548\u20133554. https:\/\/doi.org\/10.1021\/ac2002565","journal-title":"Anal Chem"},{"issue":"21","key":"852_CR14","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1021\/acs.jmedchem.8b01076","volume":"61","author":"Y Dai","year":"2018","unstructured":"Dai Y, Wynn JE, Peralta AN, Sherpa C, Jayaraman B, Li H, Verma A, Frankel AD, Le Grice SF, Santos WL (2018) Discovery of a branched peptide that recognizes the rev response element (RRE) RNA and blocks HIV-1 replication. J Med Chem 61(21):9611\u20139620. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01076","journal-title":"J Med Chem"},{"issue":"8","key":"852_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.bmc.2019.03.016","volume":"27","author":"Y Dai","year":"2019","unstructured":"Dai Y, Peralta AN, Wynn JE, Sherpa C, Li H, Verma A, Le Grice SFJ, Santos WL (2019) Molecular recognition of a branched peptide with HIV-1 rev response element (RRE) RNA. Bioorg Med Chem 27(8):1759\u20131765. https:\/\/doi.org\/10.1016\/j.bmc.2019.03.016","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"852_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4155\/FMC.13.38","volume":"5","author":"BC Das","year":"2013","unstructured":"Das BC, Thapa P, Karki R, Schinke C, Das S, Kambhampati S, Banerjee SK, Van Veldhuizen P, Verma A, Weiss LM, Evans T (2013) Boron chemicals in diagnosis and therapeutics. Future Med Chem 5(6):653\u2013676. https:\/\/doi.org\/10.4155\/FMC.13.38","journal-title":"Future Med Chem"},{"issue":"5","key":"852_CR17","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0168-9452(02)00174-7","volume":"163","author":"VM Dembitsky","year":"2002","unstructured":"Dembitsky VM, Smoum R, Al-Quntar AA, Ali HA, Pergament I, Srebnik M (2002) Natural occurrence of boron-containing compounds in plants, algae and microorganisms. Plant Sci 163(5):931\u2013942. https:\/\/doi.org\/10.1016\/S0168-9452(02)00174-7","journal-title":"Plant Sci"},{"issue":"1","key":"852_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph16010093","volume":"16","author":"JP Deng","year":"2023","unstructured":"Deng JP, Yu CS (2023) Recent development of Radiofluorination of boron agents for boron neutron capture therapy of tumor: creation of 18F-labeled C-F and B-F linkages. Pharm. 16(1):93. https:\/\/doi.org\/10.3390\/ph16010093","journal-title":"Pharm."},{"issue":"6","key":"852_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2174\/156800961466614080415451","volume":"14","author":"QP Dou","year":"2014","unstructured":"Dou QP, Zonder JA (2014) Overview of proteasome inhibitor-based anti-cancer therapies: perspective on Bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system. Curr Cancer Drug Targets 14(6):517\u2013536. https:\/\/doi.org\/10.2174\/156800961466614080415451","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"852_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1039\/D0TB01880E","volume":"9","author":"IVJ Feiner","year":"2021","unstructured":"Feiner IVJ, Pulagam KR, Uribe KB, Passannante R, Sim\u00f3 C, Zamacola K, G\u00f3mez-Vallejo V, Herrero-\u00c1lvarez N, Coss\u00edo U, Baz Z, Caffarel MM, Lawrie CH, Vugts DJ, Rejc L, Llop J (2021) Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy. J Mater Chem B 9(2):410\u2013420. https:\/\/doi.org\/10.1039\/D0TB01880E","journal-title":"J Mater Chem B"},{"issue":"19","key":"852_CR21","doi-asserted-by":"publisher","first-page":"10458","DOI":"10.1002\/ANIE.202010616","volume":"60","author":"A Franco","year":"2021","unstructured":"Franco A, da Silva JAL (2021) Boron in prebiological evolution. Angew Chem Int Ed 60(19):10458\u201310468. https:\/\/doi.org\/10.1002\/ANIE.202010616","journal-title":"Angew Chem Int Ed"},{"key":"852_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/GLYCOBIOLOGY.4E.7","volume-title":"Essentials of glycobiology","author":"P Gagneux","year":"2022","unstructured":"Gagneux P, Hennet T, Varki A (2022) Biological functions of Glycans. In: Essentials of glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. https:\/\/doi.org\/10.1101\/GLYCOBIOLOGY.4E.7"},{"issue":"21","key":"852_CR23","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/cmdc.201900508","volume":"14","author":"AK Ghosh","year":"2019","unstructured":"Ghosh AK, Xia Z, Kovela S, Robinson WL, Johnson ME, Kneller DW, Wang YF, Aoki M, Takamatsu Y, Weber IT, Mitsuya H (2019) Potent HIV-1 protease inhibitors containing carboxylic and Boronic acids: effect on enzyme inhibition and antiviral activity and protein-ligand X-Ray structural studies. Chem Med Chem 14(21):1863\u20131872. https:\/\/doi.org\/10.1002\/cmdc.201900508","journal-title":"Chem Med Chem"},{"issue":"5","key":"852_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3978\/j.issn.2223-4292.2012.09.04","volume":"2","author":"SL Gibbs","year":"2012","unstructured":"Gibbs SL (2012) Near infrared fluorescence for image-guided surgery. Quant Imaging Med Surg 2(5):177\u2013187. https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2012.09.04","journal-title":"Quant Imaging Med Surg"},{"issue":"6","key":"852_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0022-3476(53)80304-5","volume":"43","author":"RB Goldbloom","year":"1953","unstructured":"Goldbloom RB, Goldbloom A (1953) Boric acid poisoning: report of four cases and a review of 109 cases from the world literature. J Pediatr 43(6):631\u2013643. https:\/\/doi.org\/10.1016\/S0022-3476(53)80304-5","journal-title":"J Pediatr"},{"issue":"4","key":"852_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40262-018-0702-1","volume":"58","author":"N Gupta","year":"2019","unstructured":"Gupta N, Hanley MJ, Xia C, Labotka R, Harvey RD, Venkatakrishnan K (2019) Clinical pharmacology of Ixazomib: the first oral proteasome inhibitor. Clin Pharmacokinet 58(4):431\u2013449. https:\/\/doi.org\/10.1007\/s40262-018-0702-1","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"852_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES27061877","volume":"27","author":"PM Gurubasavaraj","year":"2022","unstructured":"Gurubasavaraj PM, Sajjan VP, Mu\u00f1oz-Flores BM, Jim\u00e9nez P\u00e9rez VM, Hosmane NS (2022) Recent advances in BODIPY compounds: synthetic methods, optical and nonlinear optical properties, and their medical applications. Molecules 27(6):1877. https:\/\/doi.org\/10.3390\/MOLECULES27061877","journal-title":"Molecules"},{"issue":"15","key":"852_CR28","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1016\/j.bmc.2017.05.049","volume":"25","author":"L Han","year":"2017","unstructured":"Han L, Wen Y, Li R, Xu B, Ge Z, Wang X, Cheng T, Cui J, Li R (2017) Synthesis and biological activity of peptide Proline-boronic acids as proteasome inhibitors. Bioorg Med Chem 25(15):4031\u20134044. https:\/\/doi.org\/10.1016\/j.bmc.2017.05.049","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"852_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/MMY\/MYAD074","volume":"61","author":"AF Henao-Mart\u00ednez","year":"2023","unstructured":"Henao-Mart\u00ednez AF, Corbisiero MF, Salter I, Chastain DB, Thompson GR (2023) Invasive pulmonary aspergillosis real-world outcomes: clinical features and risk factors associated with increased mortality. Med Mycol 61(8):myad074. https:\/\/doi.org\/10.1093\/MMY\/MYAD074","journal-title":"Med Mycol"},{"issue":"1","key":"852_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/S12011-018-1550-4","volume":"188","author":"JM Hunter","year":"2018","unstructured":"Hunter JM, Nemzer BV, Rangavajla N, Bi\u0163\u0103 A, Rogoveanu OC, Neam\u0163u J, Scorei IR, Bejenaru LE, R\u0103u G, Bejenaru C, Mogo\u015fanu GD (2018) The Fructoborates: part of a family of naturally occurring sugar\u2013borate complexes\u2014biochemistry, physiology, and impact on human health: a review. Biol Trace Elem Res 188(1):11\u201325. https:\/\/doi.org\/10.1007\/S12011-018-1550-4","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"852_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/sym14020182","volume":"14","author":"D Imperio","year":"2022","unstructured":"Imperio D, Panza L (2022) Sweet boron: boron-containing sugar derivatives as potential agents for boron neutron capture therapy. Symmetry (Basel) 14(2):182. https:\/\/doi.org\/10.3390\/sym14020182","journal-title":"Symmetry (Basel)"},{"issue":"7","key":"852_CR32","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1021\/acs.orglett.7b00382","volume":"19","author":"D Imperio","year":"2017","unstructured":"Imperio D, Del Grosso E, Fallarini S, Lombardi G, Panza L (2017) Synthesis of sugar\u2013boronic acid derivatives: a class of potential agents for boron neutron capture therapy. Org Lett 19(7):1678\u20131681. https:\/\/doi.org\/10.1021\/acs.orglett.7b00382","journal-title":"Org Lett"},{"key":"852_CR33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3762\/bjoc.15.135","volume":"15","author":"D Imperio","year":"2019","unstructured":"Imperio D, Del Grosso E, Fallarini S, Lombardi G, Panza L (2019) Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy. Beilstein J Org Chem 15:1355\u20131359. https:\/\/doi.org\/10.3762\/bjoc.15.135","journal-title":"Beilstein J Org Chem"},{"issue":"8","key":"852_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/cmdc.201800793","volume":"14","author":"A Isono","year":"2019","unstructured":"Isono A, Tsuji M, Sanada Y, Matsushita A, Masunaga S, Hirayama T, Nagasawa H (2019) Design, synthesis, and evaluation of Lipopeptide conjugates of Mercaptoundecahydrododecaborate for boron neutron capture therapy. Chem Med Chem 14(8):823\u2013832. https:\/\/doi.org\/10.1002\/cmdc.201800793","journal-title":"Chem Med Chem"},{"issue":"22","key":"852_CR35","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1016\/j.bmc.2018.10.041","volume":"26","author":"T Itoh","year":"2018","unstructured":"Itoh T, Tamura K, Ueda H, Tanaka T, Sato K, Kuroda R, Aoki S (2018) Design and synthesis of boron containing monosaccharides by the hydroboration of D-Glucal for use in boron neutron capture therapy (BNCT). Bioorg Med Chem 26(22):5922\u20135933. https:\/\/doi.org\/10.1016\/j.bmc.2018.10.041","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"852_CR36","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/jm500031w","volume":"57","author":"K Jansen","year":"2014","unstructured":"Jansen K, Heirbaut L, Verkerk R, Cheng JD, Joossens J, Cos P, Maes L, Lambeir AM, De Meester I, Augustyns K, Van Der Veken P (2014) Extended structure-activity relationship and pharmacokinetic investigation of (4-Quinolinoyl)Glycyl-2-Cyanopyrrolidine inhibitors of fibroblast activation protein (FAP). J Med Chem 57(7):3053\u20133074. https:\/\/doi.org\/10.1021\/jm500031w","journal-title":"J Med Chem"},{"issue":"4","key":"852_CR37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7150\/ntno.95251","volume":"8","author":"VGSS Jyothi","year":"2024","unstructured":"Jyothi VGSS, Kommineni N (2024) Peptide conjugated boron neutron capture therapy for enhanced tumor targeting. Nanotheranostics 8(4):458\u2013472. https:\/\/doi.org\/10.7150\/ntno.95251","journal-title":"Nanotheranostics"},{"issue":"6","key":"852_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1634\/theoncologist.8-6-508","volume":"8","author":"RC Kane","year":"2003","unstructured":"Kane RC, Bross PF, Farrell AT, Pazdur R (2003) Velcade\u00ae: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologia 8(6):508\u2013513. https:\/\/doi.org\/10.1634\/theoncologist.8-6-508","journal-title":"Oncologia"},{"issue":"10","key":"852_CR39","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1021\/acs.molpharmaceut.0c00478","volume":"17","author":"K Kawai","year":"2020","unstructured":"Kawai K, Nishimura K, Okada S, Sato S, Suzuki M, Takata T, Nakamura H (2020) Cyclic RGD-functionalized Closo-Dodecaborate albumin conjugates as integrin targeting boron carriers for neutron capture therapy. Mol Pharm 17(10):3740\u20133747. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00478","journal-title":"Mol Pharm"},{"issue":"1","key":"852_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/S12011-018-1284-3","volume":"186","author":"H Khaliq","year":"2018","unstructured":"Khaliq H, Juming Z, Ke-Mei P (2018) The physiological role of boron on health. Biol Trace Elem Res 186(1):31\u201351. https:\/\/doi.org\/10.1007\/S12011-018-1284-3","journal-title":"Biol Trace Elem Res"},{"issue":"18","key":"852_CR41","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1016\/j.bmcl.2014.07.086","volume":"24","author":"SS Kher","year":"2014","unstructured":"Kher SS, Penzo M, Fulle S, Finn PW, Blackman MJ, Jirgensons A (2014) Substrate derived Peptidic \u03b1-Ketoamides as inhibitors of the malarial protease PfSUB1. Bioorg Med Chem Lett 24(18):4486\u20134489. https:\/\/doi.org\/10.1016\/j.bmcl.2014.07.086","journal-title":"Bioorg Med Chem Lett"},{"issue":"15","key":"852_CR42","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1039\/C004247A","volume":"8","author":"K Knott","year":"2010","unstructured":"Knott K, Fishovitz J, Thorpe SB, Lee I, Santos WL (2010) N-terminal peptidic boronic acids selectively inhibit human ClpXP. Org Biomol Chem 8(15):3451\u20133456. https:\/\/doi.org\/10.1039\/C004247A","journal-title":"Org Biomol Chem"},{"key":"852_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471266949.bmc320","volume-title":"Burger\u2019s medicinal chemistry and drug discovery","author":"EL Krinos","year":"2025","unstructured":"Krinos EL, Gwinn RK, Santos WL (2025) Boron: the rise of a \u201cmagic-element\u201d in medicinal chemistry. In: Burger\u2019s medicinal chemistry and drug discovery. Wiley, pp 1\u201347. https:\/\/doi.org\/10.1002\/0471266949.bmc320"},{"issue":"12","key":"852_CR44","doi-asserted-by":"publisher","first-page":"13843","DOI":"10.1021\/acsnano.9b04303","volume":"13","author":"L Li","year":"2019","unstructured":"Li L, Li J, Shi Y, Du P, Zhang Z, Liu T, Zhang R, Liu Z (2019) On-demand biodegradable boron nitride nanoparticles for treating triple negative breast cancer with boron neutron capture therapy. ACS Nano 13(12):13843\u201313852. https:\/\/doi.org\/10.1021\/acsnano.9b04303","journal-title":"ACS Nano"},{"issue":"20","key":"852_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022696118","volume":"118","author":"E Lidumniece","year":"2021","unstructured":"Lidumniece E, Withers-Martinez C, Hackett F, Collins CR, Perrin AJ, Koussis K, Bisson C, Blackman MJ, Jirgensons A (2021) Peptidic Boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1. Proc Natl Acad Sci USA 118(20):e2022696118. https:\/\/doi.org\/10.1073\/pnas.2022696118","journal-title":"Proc Natl Acad Sci USA"},{"key":"852_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/NCOMMS10940","volume":"7","author":"L Mendive-Tapia","year":"2016","unstructured":"Mendive-Tapia L, Zhao C, Akram AR, Preciado S, Albericio F, Lee M, Serrels A, Kielland N, Read ND, Lavilla R, Vendrell M (2016) Spacer-free BODIPY fluorogens in antimicrobial peptides for direct imaging of fungal infection in human tissue. Nat Commun 7:10940. https:\/\/doi.org\/10.1038\/NCOMMS10940","journal-title":"Nat Commun"},{"issue":"3","key":"852_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030264","volume":"15","author":"K Messner","year":"2022","unstructured":"Messner K, Vuong B, Tranmer GK (2022) The boron advantage: the evolution and diversification of Boron\u2019s applications in medicinal chemistry. Pharm 15(3):264. https:\/\/doi.org\/10.3390\/ph15030264","journal-title":"Pharm"},{"key":"852_CR48","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jconrel.2020.11.001","volume":"330","author":"H Michiue","year":"2021","unstructured":"Michiue H, Kitamatsu M, Fukunaga A, Tsuboi N, Fujimura A, Matsushita H, Igawa K, Kasai T, Kondo N, Matsui H, Furuya S (2021) Self-assembling A6K peptide nanotubes as a Mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT). J Control Release 330:788\u2013796. https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.001","journal-title":"J Control Release"},{"issue":"9","key":"852_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-021-05311-4","volume":"23","author":"K Mikami","year":"2021","unstructured":"Mikami K, Kanetaka H, Furuya M, Yokota K, Saijo Y, Yokoi T, Kawashita M (2021) Hydrothermal synthesis and preliminary cytotoxicity assessment of gadolinium borate nanoparticles for neutron capture therapy. J Nanopart Res 23(9):201. https:\/\/doi.org\/10.1007\/s11051-021-05311-4","journal-title":"J Nanopart Res"},{"issue":"3","key":"852_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jphs.2019.01.012","volume":"139","author":"J Miyabe","year":"2019","unstructured":"Miyabe J, Ohgaki R, Saito K, Wei L, Quan L, Jin C, Liu X, Okuda S, Nagamori S, Ohki H, Yoshino K, Inohara H, Kanai Y (2019) Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter. J Pharmacol Sci 139(3):215\u2013222. https:\/\/doi.org\/10.1016\/j.jphs.2019.01.012","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"852_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/S12011-015-0590-2","volume":"172","author":"GD Mogo\u015fanu","year":"2015","unstructured":"Mogo\u015fanu GD, Bi\u0163\u0103 A, Bejenaru LE, Bejenaru C, Croitoru O, R\u0103u G, Rogoveanu OC, Florescu DN, Neam\u0163u J, Scorei ID, Scorei RI (2015) Calcium fructoborate for bone and cardiovascular health. Biolog Trace Elem Res 172(2):277\u2013281. https:\/\/doi.org\/10.1007\/S12011-015-0590-2","journal-title":"Biolog Trace Elem Res"},{"issue":"12","key":"852_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40262-012-0010-0","volume":"51","author":"P Moreau","year":"2012","unstructured":"Moreau P, Karamanesht II, Domnikova N, Kyselyova MY, Vilchevska KV, Doronin VA, Schmidt A, Hulin C, Leleu X, Esseltine DL, Venkatakrishnan K, Skee D, Feng H, Girgis S, Cakana A, Van De Velde H, Deraedt W, Facon T (2012) Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of Bortezomib in patients with relapsed multiple myeloma. Clin Pharmacokinet 51(12):823\u2013829. https:\/\/doi.org\/10.1007\/s40262-012-0010-0","journal-title":"Clin Pharmacokinet"},{"key":"852_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/DDDT.S93602","volume":"10","author":"B Muz","year":"2016","unstructured":"Muz B, Ghazarian RN, Ou M, Luderer MJ, Kusdono HD, Azab AK (2016) Spotlight on Ixazomib: potential in the treatment of multiple myeloma. Drug Des Devel Ther 10:217. https:\/\/doi.org\/10.2147\/DDDT.S93602","journal-title":"Drug Des Devel Ther"},{"issue":"93","key":"852_CR54","doi-asserted-by":"publisher","first-page":"13955","DOI":"10.1039\/C9CC03924D","volume":"55","author":"I Nakase","year":"2019","unstructured":"Nakase I, Katayama M, Hattori Y, Ishimura M, Inaura S, Fujiwara D, Takatani-Nakase T, Fujii I, Futaki S, Kirihata M (2019) Intracellular target delivery of cell-penetrating peptide-conjugated Dodecaborate for boron neutron capture therapy (BNCT). Chem Commun 55(93):13955\u201313958. https:\/\/doi.org\/10.1039\/C9CC03924D","journal-title":"Chem Commun"},{"issue":"36","key":"852_CR55","doi-asserted-by":"publisher","first-page":"22731","DOI":"10.1021\/acsomega.0c01377","volume":"5","author":"I Nakase","year":"2020","unstructured":"Nakase I, Aoki A, Sakai Y, Hirase S, Ishimura M, Takatani-Nakase T, Hattori Y, Kirihata M (2020) Antibody-based receptor targeting using an Fc-binding peptide-dodecaborate conjugate and macropinocytosis induction for boron neutron capture therapy. ACS Omega 5(36):22731\u201322738. https:\/\/doi.org\/10.1021\/acsomega.0c01377","journal-title":"ACS Omega"},{"issue":"4","key":"852_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1753-4887.2008.00023.x","volume":"66","author":"FH Nielsen","year":"2008","unstructured":"Nielsen FH (2008) Is boron nutritionally relevant? Nutr Rev 66(4):183\u2013191. https:\/\/doi.org\/10.1111\/j.1753-4887.2008.00023.x","journal-title":"Nutr Rev"},{"issue":"4","key":"852_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jtemb.2014.06.023","volume":"28","author":"FH Nielsen","year":"2014","unstructured":"Nielsen FH (2014) Update on human health effects of boron. J Trace Elem Med and Biol 28(4):383\u2013387. https:\/\/doi.org\/10.1016\/j.jtemb.2014.06.023","journal-title":"J Trace Elem Med and Biol"},{"key":"852_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1722","volume":"6","author":"T Nomoto","year":"2020","unstructured":"Nomoto T, Inoue Y, Yao Y, Suzuki M, Kanamori K, Takemoto H, Matsui M, Tomoda K, Nishiyama N (2020) Poly(vinyl alcohol) boosting therapeutic potential of p-Boronophenylalanine in neutron capture therapy by modulating metabolism. Science 6:eaaz1722. https:\/\/doi.org\/10.1126\/sciadv.aaz1722","journal-title":"Science"},{"key":"852_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2021.02.021","volume":"332","author":"T Nomoto","year":"2021","unstructured":"Nomoto T, Yao Y, Inoue Y, Suzuki M, Kanamori K, Takemoto H, Matsui M, Tomoda K, Nishiyama N (2021) Fructose-functionalized polymers to enhance therapeutic potential of p-Boronophenylalanine for neutron capture therapy. J Control Release 332:184\u2013193. https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.021","journal-title":"J Control Release"},{"issue":"5","key":"852_CR60","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10637-018-0569-x","volume":"36","author":"R Oerlemans","year":"2018","unstructured":"Oerlemans R, Berkers CR, Assaraf YG, Scheffer GL, Peters GJ, Verbrugge SE, Cloos J, Slootstra J, Meloen RH, Shoemaker RH, Dijkmans BAC, Scheper RJ, Ovaa H, Jansen G (2018) Proteasome inhibition and mechanism of resistance to a synthetic, library-based Hexapeptide. Invest New Drugs 36(5):797\u2013809. https:\/\/doi.org\/10.1007\/s10637-018-0569-x","journal-title":"Invest New Drugs"},{"issue":"2","key":"852_CR61","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/EXCR.2001.5190","volume":"265","author":"EHW Pap","year":"2001","unstructured":"Pap EHW, Dansen TB, Van Summeren R, Wirtz KWA (2001) Peptide-based targeting of fluorophores to organelles in living cells. Exp Cell Res 265(2):288\u2013293. https:\/\/doi.org\/10.1006\/EXCR.2001.5190","journal-title":"Exp Cell Res"},{"key":"852_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.610307","volume":"11","author":"GL Pereira","year":"2021","unstructured":"Pereira GL, Siqueira JA, Batista-Silva W, Cardoso FB, Nunes-Nesi A, Ara\u00fajo WL (2021) Boron: more than an essential element for land plants? Front Plant Sci 11:610307. https:\/\/doi.org\/10.3389\/fpls.2020.610307","journal-title":"Front Plant Sci"},{"key":"852_CR63","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2147\/CIA.S64590","volume":"9","author":"Z Pietrzkowski","year":"2014","unstructured":"Pietrzkowski Z, Phelan MJ, Keller R, Shu C, Argumedo R, Reyes-Izquierdo T (2014) Short-term efficacy of Calcium Fructoborate on subjects with knee discomfort: a comparative, double-blind, placebo-controlled clinical study. Clin Interv Aging 9:895. https:\/\/doi.org\/10.2147\/CIA.S64590","journal-title":"Clin Interv Aging"},{"issue":"9","key":"852_CR64","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1021\/jm400351a","volume":"56","author":"SE Poplawski","year":"2013","unstructured":"Poplawski SE, Lai JH, Li Y, Jin Z, Liu Y, Wu W, Wu Y, Zhou Y, Sudmeier JL, Sanford DG, Bachovchin WW (2013) Identification of selective and potent inhibitors of fibroblast activation protein and prolyl Oligopeptidase. J Med Chem 56(9):3467\u20133477. https:\/\/doi.org\/10.1021\/jm400351a","journal-title":"J Med Chem"},{"issue":"19","key":"852_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24193609","volume":"24","author":"KR Pulagam","year":"2019","unstructured":"Pulagam KR, Gona KB, G\u00f3mez-Vallejo V, Meijer J, Zilberfain C, Estrela-Lopis I, Baz Z, Coss\u00edo U, Llop J (2019) Gold nanoparticles as boron carriers for boron neutron capture therapy: synthesis, Radiolabelling and in vivo evaluation. Molecules 24(19):3609. https:\/\/doi.org\/10.3390\/molecules24193609","journal-title":"Molecules"},{"key":"852_CR66","first-page":"102","volume":"9","author":"L Raedler","year":"2016","unstructured":"Raedler L (2016) Ninlaro (Ixazomib): first Oral proteasome approved for the treatment of patients with relapsed or refractory myeloma. Am Health Drug Ben 9:102\u2013105","journal-title":"Am Health Drug Ben"},{"issue":"11","key":"852_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113225","volume":"10","author":"A Rondina","year":"2021","unstructured":"Rondina A, Fossa P, Orro A, Milanesi L, De Palma A, Perico D, Mauri PL, D\u2019Ursi P (2021) A boron delivery antibody (BDA) with boronated specific residues: new perspectives in boron neutron capture therapy from an in Silico investigation. Cells 10(11):3225. https:\/\/doi.org\/10.3390\/cells10113225","journal-title":"Cells"},{"key":"852_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMECH.2024.117056","volume":"282","author":"B Rong","year":"2025","unstructured":"Rong B, Dong X, Zhao W (2025) Synthesis and evaluation of a novel BODIPY fluorescent probe targeting integrin \u0391v\u03b23 for cancer diagnosis. Eur J Med Chem 282:117056. https:\/\/doi.org\/10.1016\/J.EJMECH.2024.117056","journal-title":"Eur J Med Chem"},{"issue":"18","key":"852_CR69","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1039\/D5SC01295C","volume":"16","author":"C Schad","year":"2025","unstructured":"Schad C, Ray C, D\u00edaz-Norambuena C, Serrano-Buitrago S, Moreno F, Maroto BL, Garc\u00eda-Moreno I, Mu\u00f1oz-\u00dabeda M, L\u00f3pez-Montero I, Ba\u00f1uelos J, de la Moya S (2025) Water-soluble BODIPY dyes: a novel approach for their sustainable chemistry and applied photonics. Chem Sci 16(18):8030\u20138039. https:\/\/doi.org\/10.1039\/D5SC01295C","journal-title":"Chem Sci"},{"issue":"1","key":"852_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/S11084-012-9269-2","volume":"42","author":"R Scorei","year":"2012","unstructured":"Scorei R (2012) Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on earth. Orig Life Evol Biosph 42(1):3\u201317. https:\/\/doi.org\/10.1007\/S11084-012-9269-2","journal-title":"Orig Life Evol Biosph"},{"issue":"3","key":"852_CR71","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/S12011-011-8972-6","volume":"143","author":"RI Scorei","year":"2011","unstructured":"Scorei RI, Rotaru P (2011) Calcium Fructoborate\u2013potential anti-inflammatory agent. Biol Trace Elem Res 143(3):1223\u20131238. https:\/\/doi.org\/10.1007\/S12011-011-8972-6","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"852_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/S12011-013-9800-Y","volume":"155","author":"ID Scorei","year":"2013","unstructured":"Scorei ID, Scorei RI (2013) Calcium Fructoborate helps control inflammation associated with diminished bone health. Biol Trace Elem Res 155(3):315\u2013321. https:\/\/doi.org\/10.1007\/S12011-013-9800-Y","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"852_CR73","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/S12011-011-9083-0","volume":"144","author":"R Scorei","year":"2011","unstructured":"Scorei R, Mitrut P, Petrisor I, Scorei I (2011) A double-blind, placebo-controlled pilot study to evaluate the effect of Calcium Fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res 144(1):253\u2013263. https:\/\/doi.org\/10.1007\/S12011-011-9083-0","journal-title":"Biol Trace Elem Res"},{"issue":"14","key":"852_CR74","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/cbic.202000030","volume":"21","author":"Z Sha","year":"2020","unstructured":"Sha Z, Fishovitz J, Wang S, Chilakala S, Xu Y, Lee I (2020) A selective Fluorogenic peptide substrate for the human mitochondrial ATP-dependent protease complex ClpXP. Chem Bio Chem 21(14):2037\u20132048. https:\/\/doi.org\/10.1002\/cbic.202000030","journal-title":"Chem Bio Chem"},{"key":"852_CR75","doi-asserted-by":"publisher","first-page":"18970","DOI":"10.1039\/d0ra02104k","volume":"10","author":"N Sharma","year":"2020","unstructured":"Sharma N, Barbon SM, Lalonde T, Maar RR, Milne M, Gilroy JB, Luyt LG (2020) The development of peptide-boron difluoride Formazanate conjugates as fluorescence imaging agents. RSC Adv 10:18970. https:\/\/doi.org\/10.1039\/d0ra02104k","journal-title":"RSC Adv"},{"key":"852_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40262-018-0679-9","volume":"58","author":"CRC Tan","year":"2018","unstructured":"Tan CRC, Abdul-Majeed S, Cael B, Barta SK (2018) Clinical pharmacokinetics and pharmacodynamics of Bortezomib. Clin Pharmacokinet 58:157\u2013168. https:\/\/doi.org\/10.1007\/s40262-018-0679-9","journal-title":"Clin Pharmacokinet"},{"issue":"23","key":"852_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312958","volume":"22","author":"Y Tan","year":"2021","unstructured":"Tan Y, Wu J, Song L, Zhang M, Hipolito CJ, Wu C, Wang S, Zhang Y, Yin Y (2021) Merging the versatile functionalities of boronic acid with peptides. Int J Mol Sci 22(23):12958. https:\/\/doi.org\/10.3390\/ijms222312958","journal-title":"Int J Mol Sci"},{"issue":"6","key":"852_CR78","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1248\/cpb.c17-00135","volume":"65","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Sawamoto Y, Aoki S (2017) Concise and versatile synthesis of Sulfoquinovosyl acyl glycerol derivatives for biological applications. Chem Pharm Bull (Tokyo) 65(6):566\u2013572. https:\/\/doi.org\/10.1248\/cpb.c17-00135","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"852_CR79","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.biopha.2017.08.134","volume":"95","author":"\u0141 Uram","year":"2017","unstructured":"Uram \u0141, Nizio\u0142 J, Maj P, Sobich J, Rode W, Ruman T (2017) N(4)-[B-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan)methyl]-2\u2019-deoxycytidine as a potential boron delivery agent with respect to glioblastoma. Biomed Pharmacother 95:749\u2013755. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.134","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"852_CR80","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2174\/1385272023373446","volume":"6","author":"W Wang","year":"2005","unstructured":"Wang W, Gao X, Wang B (2005) Boronic acid-based sensors. Curr Org Chem 6(14):1285\u20131317. https:\/\/doi.org\/10.2174\/1385272023373446","journal-title":"Curr Org Chem"},{"issue":"9","key":"852_CR81","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.9b00464","volume":"16","author":"S Wang","year":"2019","unstructured":"Wang S, Blaha C, Santos R, Huynh T, Hayes TR, Beckford-Vera DR, Blecha JE, Hong AS, Fogarty M, Hope TA, Raleigh DR, Wilson DM, Evans MJ, VanBrocklin HF, Ozawa T, Flavell RR (2019) Synthesis and initial biological evaluation of boron-containing prostate-specific membrane antigen ligands for treatment of prostate cancer using boron neutron capture therapy. Mol Pharm 16(9):3831\u20133841. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b00464","journal-title":"Mol Pharm"},{"key":"852_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.788770","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang Z, Miao L, Li Y (2022a) Boron neutron capture therapy: current status and challenges. Front Oncol 12:788770. https:\/\/doi.org\/10.3389\/fonc.2022.788770","journal-title":"Front Oncol"},{"issue":"1","key":"852_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41391-021-00394-5","volume":"25","author":"F Wang","year":"2022","unstructured":"Wang F, Li Z, Feng X, Yang D, Lin M (2022b) Advances in PSMA-targeted therapy for prostate cancer. Prostate Cancer Prostatic Dis 25(1):11\u201326. https:\/\/doi.org\/10.1038\/s41391-021-00394-5","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"852_CR84","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/nph.16127","volume":"226","author":"MA Wimmer","year":"2020","unstructured":"Wimmer MA, Abreu I, Bell RW, Bienert MD, Brown PH, Dell B, Fujiwara T, Goldbach HE, Lehto T, Mock HP, von Wir\u00e9n N, Bassil E, Bienert GP (2020) Boron: an essential element for vascular plants. New Phytol 226(5):1232\u20131237. https:\/\/doi.org\/10.1111\/nph.16127","journal-title":"New Phytol"},{"issue":"43","key":"852_CR85","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1021\/jacs.8b07366","volume":"140","author":"IW Windsor","year":"2018","unstructured":"Windsor IW, Palte MJ, Lukesh JC, Gold B, Forest KT, Raines RT (2018) Sub-picomolar inhibition of HIV-1 protease with a boronic acid. J Am Chem Soc 140(43):14015\u201314018. https:\/\/doi.org\/10.1021\/jacs.8b07366","journal-title":"J Am Chem Soc"},{"issue":"17","key":"852_CR86","first-page":"1018","volume":"90","author":"LC Wong","year":"1964","unstructured":"Wong LC, Heimach MD, Truscott DR, Duncan BD (1964) Boric acid poisoning: report of 11 cases. Can Med Assoc J 90(17):1018","journal-title":"Can Med Assoc J"},{"issue":"5","key":"852_CR87","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/acs.jmedchem.9b01136","volume":"63","author":"DJ Worm","year":"2020","unstructured":"Worm DJ, Hoppenz P, Els-Heindl S, Kellert M, Kuhnert R, Saretz S, K\u00f6bberling J, Riedl B, Hey-Hawkins E, Beck-Sickinger AG (2020) Selective neuropeptide Y conjugates with maximized carborane loading as promising boron delivery agents for boron neutron capture therapy. J Med Chem 63(5):2358\u20132371. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01136","journal-title":"J Med Chem"},{"issue":"21","key":"852_CR88","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1039\/c5ob00589b","volume":"13","author":"JE Wynn","year":"2015","unstructured":"Wynn JE, Santos WL (2015) HIV-1 drug discovery: targeting folded RNA structures with branched peptides. Org Biomol Chem 13(21):5848\u20135858. https:\/\/doi.org\/10.1039\/c5ob00589b","journal-title":"Org Biomol Chem"},{"issue":"7","key":"852_CR89","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1039\/c6md00171h","volume":"7","author":"JE Wynn","year":"2016","unstructured":"Wynn JE, Zhang W, Tebit DM, Gray LR, Hammarskjold ML, Rekosh D, Santos WL (2016a) Effect of intercalator and Lewis acid-base branched peptide complex formation: boosting affinity towards HIV-1 RRE RNA. Med Chem Commun 7(7):1436\u20131440. https:\/\/doi.org\/10.1039\/c6md00171h","journal-title":"Med Chem Commun"},{"issue":"17","key":"852_CR90","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1016\/j.bmc.2016.04.009","volume":"24","author":"JE Wynn","year":"2016","unstructured":"Wynn JE, Zhang W, Tebit DM, Gray LR, Hammarskjold M-L, Rekosh D, Santos WL (2016b) Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA. Bioorg Med Chem 24(17):3947\u20133952. https:\/\/doi.org\/10.1016\/j.bmc.2016.04.009","journal-title":"Bioorg Med Chem"},{"issue":"2013","key":"852_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/srep02679","volume":"58","author":"XD Xu","year":"2013","unstructured":"Xu XD, Cheng H, Chen WH, Cheng SX, Zhuo RX, Zhang XZ (2013) In situ recognition of cell-surface glycans and targeted imaging of cancer cells. Sci Rep 58(2013):2679. https:\/\/doi.org\/10.1038\/srep02679","journal-title":"Sci Rep"},{"issue":"24","key":"852_CR92","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1039\/C3CC00243H","volume":"49","author":"W Zhang","year":"2013","unstructured":"Zhang W, Bryson DI, Crumpton JB, Wynn J, Santos WL (2013a) Branched Peptideboronic acids (BPBAs): a novel mode of binding towards RNA. Chem Commun 49(24):2436\u20132438. https:\/\/doi.org\/10.1039\/C3CC00243H","journal-title":"Chem Commun"},{"issue":"37","key":"852_CR93","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1039\/C3OB41053F","volume":"11","author":"W Zhang","year":"2013","unstructured":"Zhang W, Bryson DI, Crumpton JB, Wynn J, Santos WL (2013b) Targeting folded RNA: a branched Peptideboronic acid that binds to a large surface area of HIV-1 RRE RNA. Org Biomol Chem 11(37):6263\u20136271. https:\/\/doi.org\/10.1039\/C3OB41053F","journal-title":"Org Biomol Chem"}],"container-title":["Handbook of Experimental Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2026_852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:39:22Z","timestamp":1789202362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2026_852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":93,"URL":"https:\/\/doi.org\/10.1007\/164_2026_852","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"13 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}